As the Trump administration cracks down on the H-1B visa program, which allows skilled workers like software engineers to ...
Drug developers weigh building internal radiopharmaceutical capabilities versus outsourcing amid timeline and funding ...
The number of drugs in development has fallen for the first time since the mid-1990s, according to a Citeline report. | The ...
After securing a multibillion-dollar biobucks deal with AstraZeneca and raising nearly $100 million last year, peptide drug ...
Cyclerion stock soared on a merger agreement with privately held Korsana Biosciences. But there are ample reasons for ...
Serina Therapeutics, Inc. (“Serina” or the "Company") (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, today reported ...
HXN-1001 is a half-life extended, next generation anti-TL1A antibody with great potential for the treatment of patients with inflammatory bowel disease (IBD) including ulcerative colitis and Crohn’s ...
Zenas BioPharma (ZBIO) faces a catalyst-rich 2026, with the key milestone being the planned BLA submission for obexelimab in ...
Nanobiotix S.A. (NASDAQ:NBTX) Q4 2025 Earnings Call Transcript April 1, 2026 Operator: Good day, and thank you for standing ...
Morning Overview on MSN
New compound clears toxic tau in lab model of frontotemporal dementia
Researchers at Washington University School of Medicine in St. Louis have shown that a small chemical compound can restore ...
NEW YORK, NY, UNITED STATES, April 3, 2026 /EINPresswire.com/ -- The IoT healthcare market reached $176 billion in 2025 ...
Across the Princeton campus and beyond, groundbreaking biomedical advances are emerging from interdisciplinary partnerships ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results